chr1-92246626-GAA-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_053274.3(GLMN):c.1687_1688del(p.Phe563HisfsTer3) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
GLMN
NM_053274.3 frameshift
NM_053274.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.55
Genes affected
GLMN (HGNC:14373): (glomulin, FKBP associated protein) This gene encodes a phosphorylated protein that is a member of a Skp1-Cullin-F-box-like complex. The protein is essential for normal development of the vasculature and mutations in this gene have been associated with glomuvenous malformations, also called glomangiomas. Multiple splice variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0549 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLMN | NM_053274.3 | c.1687_1688del | p.Phe563HisfsTer3 | frameshift_variant | 19/19 | ENST00000370360.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLMN | ENST00000370360.8 | c.1687_1688del | p.Phe563HisfsTer3 | frameshift_variant | 19/19 | 1 | NM_053274.3 | P1 | |
GLMN | ENST00000495106.5 | c.*348_*349del | 3_prime_UTR_variant, NMD_transcript_variant | 18/18 | 1 | ||||
GLMN | ENST00000471465.1 | n.633_634del | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Glomuvenous malformation Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Clinical Genomics Laboratory, Washington University in St. Louis | Sep 01, 2023 | The GLMN c.1687_1688del (p.Phe563HisfsTer3) variant was identified at an allelic fraction consistent with somatic origin. This variant, to our knowledge, has not been reported in the medical literature. This variant is absent from the general population (gnomAD v.3.1.2), indicating it is not a common variant. This variant causes a frameshift by deleting two nucleotides, leading to a premature termination codon; however, because this occurs in the last exon, this is not predicted to lead to nonsense-mediated decay. Loss-of-function variants have been reported in glomuvenous malformation and Blue rubber bleb nevus syndrome (Brouillard P et al., PMID: 15689436, Borroni RG et al., PMID: 24961656; Borroni RG et al., PMID: 24345188; Brouillard P et al., PMID: 23801931; Amyere M et al., PMID: 23375657; Brouillard P et al., PMID: 11845407; Yin J et al., PMID: 31793416). A concurrent variant at a heterozygous allelic fraction, GLMN c.395-1G>C, is identified; however, whether these variants are in cis or trans, can not be determined by this assay. The GLMN c.1687_1688del (p.Phe563HisfsTer3) variant is predicted to result in a loss of function allele. The two-hit model for glomuvenous malformations involving the GLMN gene has been reported in the literature (Brouillard P et al., PMID: 23801931; Brouillard P et al., PMID: 15689436; Amyere M et al., PMID: 23375657; Amyere M et al., PMID: 23375657; Borroni RG et al., PMID: 24961656; Brouillard et al., PMID: 11845407). Due to limited information and based on an internally-developed protocol informed by the ACMG/AMP guidelines (Richards S et al., PMID: 25741868) and gene-specific practices from the ClinGen Criteria Specification Registry, the clinical significance of this variant is uncertain at this time. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.